No abstract available
MeSH terms
-
Adrenergic beta-Antagonists / therapeutic use
-
Angiotensin II Type 1 Receptor Blockers / therapeutic use
-
Angiotensin-Converting Enzyme Inhibitors / therapeutic use
-
Clinical Trials as Topic
-
Heart Failure / drug therapy
-
Heart Failure / mortality
-
Heart Failure / physiopathology*
-
Heart Rate
-
Homeostasis
-
Humans
-
Myocardial Contraction
-
Nerve Growth Factor / physiology
-
Nerve Growth Factor / therapeutic use
-
Norepinephrine / blood
-
Receptors, Adrenergic, beta
-
Sympathetic Nervous System / physiology*
-
Time Factors
-
Up-Regulation
-
Ventricular Dysfunction / physiopathology
-
Ventricular Remodeling / physiology
Substances
-
Adrenergic beta-Antagonists
-
Angiotensin II Type 1 Receptor Blockers
-
Angiotensin-Converting Enzyme Inhibitors
-
Receptors, Adrenergic, beta
-
Nerve Growth Factor
-
Norepinephrine